Hundreds of thousands of people are expected to be saved: How does it work, and how much is the fantastic antidote to the coronary?

Great news has just arrived from Great Britain, which Periscope reported. An existing drug called “examatena” (dexamethason) has achieved fantastic results in the fight of coronary and even the most ill patients. Of the 20 persons who receive the Coronervirus, 19 pass it completely. [...]
Of the 20 people who receive the choreography, 19 pass it without having to go to the hospital. But even those admitted to the hospital do better. Others, however, need ossygenosis or mechanical ventilation.
These are the people in high risk who seem to be helping, writes BBC, translate Periscope.
The medicine is already in use to reduce inflammation to a variety of other health conditions, and it seems to do much to some of the damage that can happen when the body's immune system is exhausted by trying to fight the virus.
Super-responsive response called the cytokin storm and can be deadly.

In testing, led by Oxford University, about 2 thousand hospital patients received dexemetazone and were compared to more than 40,000 who had not received it.
For ventilator patients, the risk of death was reduced from 40 to 28 percent. For patients with oxygen therapy, the risk of death was reduced from 25% to 20%.
This is the only drug so far that has shown that it can reduce mortality and even significantly reduce it. It's an extraordinary discovery. ”
The market's dexemetazone price cost less than 10 euros. /Periscope












